Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.

Cancer cell | Jul 18, 2005

http://www.ncbi.nlm.nih.gov/pubmed/16023600

Gankyrin is an ankyrin repeat oncoprotein commonly overexpressed in hepatocellular carcinomas. Gankyrin interacts with the S6 proteasomal ATPase and accelerates the degradation of the tumor suppressor Rb. We show here that gankyrin has an antiapoptotic activity in cells exposed to DNA damaging agents. Downregulation of gankyrin induces apoptosis in cells with wild-type p53. In vitro and in vivo experiments revealed that gankyrin binds to Mdm2, facilitating p53-Mdm2 binding, and increases ubiquitylation and degradation of p53. Gankyrin also enhances Mdm2 autoubiquitylation in the absence of p53. Downregulation of gankyrin reduced amounts of Mdm2 and p53 associated with the 26S proteasome. Thus, gankyrin is a cofactor that increases the activities of Mdm2 on p53 and probably targets polyubiquitylated p53 into the 26S proteasome.

Pubmed ID: 16023600 RIS Download

Mesh terms: Animals | Ankyrins | Apoptosis | Cells, Cultured | Gene Expression Regulation | Humans | Immunoprecipitation | Mice | Molecular Sequence Data | Neoplasms | Nuclear Proteins | Proteasome Endopeptidase Complex | Proteasome Inhibitors | Proto-Oncogene Proteins | Proto-Oncogene Proteins c-mdm2 | RNA, Small Interfering | Retinoblastoma Protein | Tumor Suppressor Protein p53 | Zinc Fingers

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.